OCLN and infectious otitis media: In an AOM/DSS mouse model, 6-week sucralose supplementation (1.5 mg/ml) prior to AOM/DSS treatment increased mucosal occludin, claudin-1, and claudin-4 (vs. mice that were not supplemented) (6).